Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma
Clinical trial NCT03023527 · TERMINATED
Trial details
- NCT number
- NCT03023527
- Sponsor
- PETHEMA Foundation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-01-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.